Media Coverage

Stay informed and keep abreast with our media news.

08 September 2025
CNA Video
Mirxes joining Hang Seng Composite Index
Learn More
26 August 2025
Business Times
A*Star biotech spin-off Mirxes trims losses to US$28.4 million as top line grows
Learn More
26 August 2025
Lianhe Zaobao
新加坡生物科技公司觅瑞 上半年净亏减36.3%至3640万元
Learn More
26 August 2025
Tech In Asia
Mirxes narrow losses as H1 revenue rises to $10.5m
Learn More
26 August 2025
CNBC
Singapore biotech firm Mirxes lays out profitability timeline
Learn More
25 August 2025
Straits Times
Singapore biotech start-up Mirxes to join Hang Seng Composite Index 3 months after Hong Kong IPO
Learn More
24 August 2025
Business Times
Singapore-headquarted Mirxes to join Alibaba, tencent on Hang Seng Composite Index
Learn More
24 August 2025
Lianhe Zaobao
香港上市的新加坡公司觅瑞被纳入恒生综合指数
Learn More
01 August 2025
Lianhe Zaobao
觅瑞与日本长和药品合作 推动早期癌症检测创新
Learn More
02 June 2025
Straits Times
S’pore’s billion-dollar biotech firm: Life sciences scholar leads start-up to list in HK
Learn More
24 May 2025
Tech In Asia
Mirxes becomes SEA’s first biotech unicorn after HK IPO
Learn More
23 May 2025
Xinhua News Agency
新加坡生物科技公司觅瑞集团在港上市
Learn More
23 May 2025
Lianhe Zaobao
新加坡生物科企觅瑞香港上市首日大涨近三成 未来拟在新交所第二上市
Learn More
23 May 2025
CNBC
HK debutant Mirxes says China-Singapore ‘dual engine’ will drive growth amid global changes
Learn More
23 May 2025
Bloomberg
Mirxes Says China Will Be An Important Market
Learn More
15 May 2025
Business Times
Singapore biotech firm Mirxes launches IPO in Hong Kong to raise HK$1 billion
Learn More
15 May 2025
Straits Times
Singapore biotech start-up Mirxes launches IPO in Hong Kong to raise $181 million
Learn More
15 May 2025
South China Morning Post
Billion-dollar Hong Kong IPOs keep coming as China’s biggest drug company joins rush
Learn More
24 January 2025
Lianhe Zaobao
Singapore biotech firm Mirxes launches IPO in Hong Kong to raise HK$1 billion
Learn More
13 January 2025
Tech In Asia
Mirxes secures $40m to expand cancer diagnostics in Asia
Learn More
14 June 2024
BioSpectrum
Thermo Fisher, NUH, Mirxes collaborate to enhance access to early cancer detection genomic tests in Singapore
Learn More
28 May 2024
Straits Times
S’pore biotech start-up Mirxes refiles for Hong Kong IPO, eyes growth in China
Learn More
19 May 2024
South China Morning Post
China is key market for Singaporean biotech start-up’s stomach cancer early diagnosis kit
Learn More
17 May 2024
Lianhe Zaobao
觅瑞生物与国立癌症中心合作开发 血液检测技术筛查肝硬化
Learn More
14 May 2024
Straits Times
New genetic testing lab helps pinpoint targeted treatment for cancer patients in S’pore, region
Learn More
13 May 2024
BioSpectrum
Singapore unveils first public-private partnership center for specialty molecular testing
Learn More
13 May 2024
Lianhe Zaobao
国大医院与私企合办实验室 癌患基因检测更快更便宜
Learn More
13 May 2024
8 World
国大医院与私人领域合作 提供先进癌症诊断测试
Learn More
07 May 2024
Lianhe Zaobao
觅瑞更新招股书 筹集至少1亿美元
Learn More
07 May 2024
TheEdge
Singapore biotech firm Mirxes refiles HK IPO with target valuation of US$600 million
Learn More

Investor Relations
Investor Relations